Cargando…

Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers

The use of tumor markers aids in the early detection of cancer recurrence and prognosis. There is a hope that they might also be useful in screening tests for the early detection of cancer. Here, the question of finding ideal tumor markers, which should be sensitive, specific, and reliable, is an ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Naryzhny, Stanislav, Ronzhina, Natalia, Zorina, Elena, Kabachenko, Fedor, Klopov, Nikolay, Zgoda, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569744/
https://www.ncbi.nlm.nih.gov/pubmed/36232415
http://dx.doi.org/10.3390/ijms231911113
_version_ 1784809930759340032
author Naryzhny, Stanislav
Ronzhina, Natalia
Zorina, Elena
Kabachenko, Fedor
Klopov, Nikolay
Zgoda, Victor
author_facet Naryzhny, Stanislav
Ronzhina, Natalia
Zorina, Elena
Kabachenko, Fedor
Klopov, Nikolay
Zgoda, Victor
author_sort Naryzhny, Stanislav
collection PubMed
description The use of tumor markers aids in the early detection of cancer recurrence and prognosis. There is a hope that they might also be useful in screening tests for the early detection of cancer. Here, the question of finding ideal tumor markers, which should be sensitive, specific, and reliable, is an acute issue. Human plasma is one of the most popular samples as it is commonly collected in the clinic and provides noninvasive, rapid analysis for any type of disease including cancer. Many efforts have been applied in searching for “ideal” tumor markers, digging very deep into plasma proteomes. The situation in this area can be improved in two ways—by attempting to find an ideal single tumor marker or by generating panels of different markers. In both cases, proteomics certainly plays a major role. There is a line of evidence that the most abundant, so-called “classical plasma proteins”, may be used to generate a tumor biomarker profile. To be comprehensive these profiles should have information not only about protein levels but also proteoform distribution for each protein. Initially, the profile of these proteins in norm should be generated. In our work, we collected bibliographic information about the connection of cancers with levels of “classical plasma proteins”. Additionally, we presented the proteoform profiles (2DE patterns) of these proteins in norm generated by two-dimensional electrophoresis with mass spectrometry and immunodetection. As a next step, similar profiles representing protein perturbations in plasma produced in the case of different cancers will be generated. Additionally, based on this information, different test systems can be developed.
format Online
Article
Text
id pubmed-9569744
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95697442022-10-17 Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers Naryzhny, Stanislav Ronzhina, Natalia Zorina, Elena Kabachenko, Fedor Klopov, Nikolay Zgoda, Victor Int J Mol Sci Article The use of tumor markers aids in the early detection of cancer recurrence and prognosis. There is a hope that they might also be useful in screening tests for the early detection of cancer. Here, the question of finding ideal tumor markers, which should be sensitive, specific, and reliable, is an acute issue. Human plasma is one of the most popular samples as it is commonly collected in the clinic and provides noninvasive, rapid analysis for any type of disease including cancer. Many efforts have been applied in searching for “ideal” tumor markers, digging very deep into plasma proteomes. The situation in this area can be improved in two ways—by attempting to find an ideal single tumor marker or by generating panels of different markers. In both cases, proteomics certainly plays a major role. There is a line of evidence that the most abundant, so-called “classical plasma proteins”, may be used to generate a tumor biomarker profile. To be comprehensive these profiles should have information not only about protein levels but also proteoform distribution for each protein. Initially, the profile of these proteins in norm should be generated. In our work, we collected bibliographic information about the connection of cancers with levels of “classical plasma proteins”. Additionally, we presented the proteoform profiles (2DE patterns) of these proteins in norm generated by two-dimensional electrophoresis with mass spectrometry and immunodetection. As a next step, similar profiles representing protein perturbations in plasma produced in the case of different cancers will be generated. Additionally, based on this information, different test systems can be developed. MDPI 2022-09-21 /pmc/articles/PMC9569744/ /pubmed/36232415 http://dx.doi.org/10.3390/ijms231911113 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Naryzhny, Stanislav
Ronzhina, Natalia
Zorina, Elena
Kabachenko, Fedor
Klopov, Nikolay
Zgoda, Victor
Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title_full Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title_fullStr Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title_full_unstemmed Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title_short Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers
title_sort construction of 2de patterns of plasma proteins: aspect of potential tumor markers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569744/
https://www.ncbi.nlm.nih.gov/pubmed/36232415
http://dx.doi.org/10.3390/ijms231911113
work_keys_str_mv AT naryzhnystanislav constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers
AT ronzhinanatalia constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers
AT zorinaelena constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers
AT kabachenkofedor constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers
AT klopovnikolay constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers
AT zgodavictor constructionof2depatternsofplasmaproteinsaspectofpotentialtumormarkers